{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:12:13Z","timestamp":1790611933334,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"7th Framework Programme of the European Union FIGHT-MG","award":["242210"],"award-info":[{"award-number":["242210"]}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institute of Myology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jaut.2013.12.011","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T00:00:16Z","timestamp":1388793616000},"page":"90-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":341,"special_numbering":"C","title":["Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms"],"prefix":"10.1016","volume":"52","author":[{"given":"Sonia","family":"Berrih-Aknin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.12.011_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A\u00a0systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mus.880080311","article-title":"Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates","volume":"8","author":"Pestronk","year":"1985","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2013.12.011_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0022-510X(83)90095-3","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients","volume":"58","author":"Limburg","year":"1983","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jaut.2013.12.011_bib5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/WCO.0b013e328364d6cd","article-title":"Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation","volume":"26","author":"Le Panse","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.011_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.011_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0896-8411(91)90017-7","article-title":"Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance","volume":"4","author":"Eymard","year":"1991","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1172\/JCI117302","article-title":"Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction","volume":"94","author":"Guyon","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.12.011_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI1248","article-title":"Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss","volume":"102","author":"Guyon","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.12.011_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.410210309","article-title":"Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types","volume":"21","author":"Kida","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib13","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2013.12.011_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21628","article-title":"CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia","volume":"66","author":"Berrih-Aknin","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib15","first-page":"6","article-title":"Role of the thymus in the physiopathology of myasthenia","volume":"151","author":"Eymard","year":"1995","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jaut.2013.12.011_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0404.1989.tb03881.x","article-title":"Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy","volume":"80","author":"Thorlacius","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jaut.2013.12.011_bib17","first-page":"369","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1468-1331.2007.01785.x","article-title":"Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features","volume":"14","author":"Romi","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","article-title":"Myasthenia gravis: a higher than expected incidence in the elderly","volume":"60","author":"Aragones","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib20","first-page":"2015","article-title":"Myasthenia gravis: a changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in\u00a0vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.12.011_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/35074025","article-title":"Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse","volume":"410","author":"Lin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.12.011_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jaut.2013.12.011_bib24","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2013.12.011_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2013.12.011_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.12.011_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A Comprehensive Analysis of the Epidemiology and Clinical Characteristics of Anti-LRP4 in Myasthenia Gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib32","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and\u00a0pathogenic relevance of antibodies to clustered acetylcholine receptor\u00a0in\u00a0ocular and generalized myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2012.06833.x","article-title":"The search for new antigenic targets in myasthenia gravis","volume":"1275","author":"Cossins","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.011_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ni723","article-title":"Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self","volume":"2","author":"Derbinski","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.191.6.1051","article-title":"An essential role for thymic mesenchyme in early T cell development","volume":"191","author":"Suniara","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.12.011_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.cdd.4401611","article-title":"Thymic myoid cells protect thymocytes from apoptosis and modulate their differentiation: implication of the ERK and Akt signaling pathways","volume":"12","author":"Le Panse","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jaut.2013.12.011_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.011_bib38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1309\/CAV8RNU5TKNACKNC","article-title":"Thymoma classification: current status and future trends","volume":"125","author":"Suster","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaut.2013.12.011_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","article-title":"Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study","volume":"44","author":"Filosso","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jaut.2013.12.011_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.011_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2013.12.018","article-title":"Thymoma-associated myasthenia gravis: on the search for a pathogen signature","volume":"52","author":"Cufi","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.34.1.66","article-title":"Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis","volume":"34","author":"Berrih","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib45","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.145.7.2115","article-title":"Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis","volume":"145","author":"Leprince","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib46","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4049\/jimmunol.137.4.1221","article-title":"Antibodies to acetylcholine receptor and tetanus toxoid: in\u00a0vitro synthesis by thymic lymphocytes","volume":"137","author":"Lisak","year":"1986","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00915728","article-title":"In\u00a0vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions","volume":"7","author":"Safar","year":"1987","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.136.3.887","article-title":"Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis","volume":"136","author":"Fujii","year":"1986","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1600-0404.2001.00209.x","article-title":"Analysis of immunoglobulin secretion by lymph organs with myasthenia gravis","volume":"103","author":"Yoshikawa","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jaut.2013.12.011_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Schonbeck","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.12.011_bib51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1531-8249(199910)46:4<559::AID-ANA3>3.0.CO;2-S","article-title":"Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis","volume":"46","author":"Aissaoui","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.12.011_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12 recruits B cells and antigen-presenting cells to the thymus of\u00a0autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2013.12.011_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2013.12.011_bib55","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neurol.2013.02.005","article-title":"The thymus in autoimmune Myasthenia gravis: paradigm for a tertiary lymphoid organ","volume":"169","author":"Weiss","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jaut.2013.12.011_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.12.011_bib57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1084\/jem.20021761","article-title":"Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase","volume":"197","author":"Drayton","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.12.011_bib58","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B\u00a0cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.12.011_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2005.09.001","article-title":"Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients","volume":"170","author":"Saito","year":"2005","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib63","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Poea-Guyon","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib64","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.12.011_bib65","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.V92.4.1297","article-title":"Two signaling pathways can increase fas expression in human thymocytes","volume":"92","author":"Moulian","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.12.011_bib66","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood.V89.9.3287","article-title":"Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody","volume":"89","author":"Moulian","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.12.011_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0896-8411(89)90267-9","article-title":"High recombinant interleukin-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: correlations with clinical parameters","volume":"2","author":"Cohen-Kaminsky","year":"1989","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-5728(94)90080-9","article-title":"Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis","volume":"51","author":"Link","year":"1994","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib69","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-\u03b1","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-2776(03)81008-8","article-title":"Control of autoimmunity by naturally arising regulatory CD4+ T cells","volume":"81","author":"Hori","year":"2003","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib72","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib73","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2013.12.011_bib74","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1212\/WNL.0b013e3181d31e47","article-title":"Undiminished regulatory T cells in the thymus of patients with myasthenia gravis","volume":"74","author":"Matsui","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib75","first-page":"54","article-title":"Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study","volume":"19","author":"Battaglia","year":"2005","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"key":"10.1016\/j.jaut.2013.12.011_bib76","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","article-title":"Functional defect in regulatory T cells in myasthenia gravis","volume":"1274","author":"Thiruppathi","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.011_bib77","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaut.2013.12.011_bib78","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2012.06791.x","article-title":"Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17","volume":"1274","author":"Gradolatto","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.011_bib80","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2013.12.011_bib81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","article-title":"Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients","volume":"225","author":"Masuda","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T\u00a0helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib83","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF00918185","article-title":"In\u00a0vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis","volume":"11","author":"Aime","year":"1991","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib84","first-page":"121","article-title":"Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia","volume":"4","author":"Cohen-Kaminsky","year":"1993","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaut.2013.12.011_bib85","first-page":"1798","article-title":"Thymectomy: role in the treatment of myasthenia gravis","volume":"260","author":"Spillane","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0003-4975(01)02678-9","article-title":"Predictors of outcome in thymectomy for myasthenia gravis","volume":"72","author":"Budde","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jaut.2013.12.011_bib87","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0003-4975(99)00310-0","article-title":"Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases","volume":"67","author":"Nieto","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jaut.2013.12.011_bib88","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0022-5223(03)00938-3","article-title":"The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer","volume":"126","author":"Okumura","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jaut.2013.12.011_bib89","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1196\/annals.1405.014","article-title":"Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone","volume":"1132","author":"Newsom-Davis","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.011_bib90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1375\/twin.14.2.129","article-title":"Utilizing twins concordance rates to infer the predisposition to myasthenia gravis","volume":"14","author":"Ramanujam","year":"2011","journal-title":"Twin Res Hum Genet"},{"issue":"Suppl","key":"10.1016\/j.jaut.2013.12.011_bib91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2005.09.010","article-title":"Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex","volume":"25","author":"Vandiedonck","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib92","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.011_bib93","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib94","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of autoimmune myasthenia gravis - A comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.011_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(98)00253-7","article-title":"Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis","volume":"94","author":"Huang","year":"1999","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib96","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: Innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.011_bib97","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e318260cbd0","article-title":"A\u00a0candidate gene for autoimmune myasthenia gravis","volume":"79","author":"Landoure","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib98","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro-->Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib99","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.4049\/jimmunol.179.6.3662","article-title":"Characterization of early stages of human B cell development by gene expression profiling","volume":"179","author":"Hystad","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib100","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2011.150102","article-title":"Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2013.12.011_bib101","article-title":"Identification of TNIP1 polymorphisms by high resolution melting analysis with unlabelled probe: association with systemic lupus erythematosus","volume":"2012","author":"Zhang","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jaut.2013.12.011_bib102","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ni1110","article-title":"The ubiquitin-modifying enzyme A20 is required for termination of toll-like receptor responses","volume":"5","author":"Boone","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib103","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1084\/jem.20102177","article-title":"Polyubiquitin binding to ABIN1 is required to prevent autoimmunity","volume":"208","author":"Nanda","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.12.011_bib104","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaut.2013.12.011_bib105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2013.12.011_bib106","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.4049\/jimmunol.0801613","article-title":"Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes","volume":"182","author":"Alsaleh","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib107","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.4049\/jimmunol.0803560","article-title":"MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression","volume":"182","author":"Lu","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib108","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib109","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10875-012-9834-5","article-title":"MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1","volume":"33","author":"Cheng","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2012.06.007","article-title":"Specific immunotherapy of experimental myasthenia gravis in\u00a0vitro and in\u00a0vivo: the guided missile strategy","volume":"251","author":"Sun","year":"2012","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/eurjhf\/hfr155","article-title":"Serum levels of microRNAs in patients with heart failure","volume":"14","author":"Goren","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaut.2013.12.011_bib112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.07.003","article-title":"Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells","volume":"14","author":"Jiang","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaut.2013.12.011_bib113","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.23880","article-title":"Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis","volume":"73","author":"Gandhi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib114","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/gene.2010.53","article-title":"Let-7\/miR-98 regulate Fas and Fas-mediated apoptosis","volume":"12","author":"Wang","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaut.2013.12.011_bib115","doi-asserted-by":"crossref","first-page":"A479","DOI":"10.1016\/j.autrev.2011.11.022","article-title":"The influence of sex and gender on the immune response","volume":"11","author":"Oertelt-Prigione","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.011_bib116","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000331437","article-title":"Estrogen stimulates Th2 cytokine production and regulates the compartmentalisation of eosinophils during allergen challenge in a mouse model of asthma","volume":"158","author":"Cai","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib117","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaut.2013.12.011_bib118","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1073\/pnas.0307915100","article-title":"Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene","volume":"101","author":"Shim","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.12.011_bib119","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.163.8.4168","article-title":"Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations","volume":"163","author":"Staples","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/cimm.1994.1038","article-title":"Glucocorticoid independence of acute thymic involution induced by lymphotoxin and estrogen","volume":"153","author":"Hirahara","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib121","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jcp.21221","article-title":"Induction of regulatory T cells by physiological level estrogen","volume":"214","author":"Tai","year":"2008","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jaut.2013.12.011_bib122","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.40.11.1060","article-title":"Acetylcholinesterase activity and menstrual remissions in myasthenia gravis","volume":"40","author":"Vijayan","year":"1977","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jaut.2013.12.011_bib123","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0035-3787(06)75019-6","article-title":"Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase","volume":"162","author":"Ramirez","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jaut.2013.12.011_bib124","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential estrogen receptor expression in autoimmune myasthenia gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2013.12.011_bib125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1468-1331.2000.00042.x","article-title":"Effects of sex hormones on experimental autoimmune myasthenia gravis","volume":"7","author":"Leker","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib126","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.175.8.5050","article-title":"Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses","volume":"175","author":"Delpy","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib127","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.ppat.0020062","article-title":"The thymus is a common target organ in infectious diseases","volume":"2","author":"Savino","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaut.2013.12.011_bib128","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.0b013e3181d7d884","article-title":"Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis","volume":"74","author":"Cavalcante","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.23869","article-title":"West nile virus infection and myasthenia gravis","volume":"49","author":"Leis","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2013.12.011_bib130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2008.06.028","article-title":"Thymus and Myasthenia Gravis: what can we learn from DNA microarrays?","volume":"201-202","author":"Cizeron-Clairac","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.011_bib131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2013.12.011_bib132","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib133","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib134","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.20081761","article-title":"Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3","volume":"206","author":"Iwakiri","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.12.011_bib135","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2011.03636.x","article-title":"High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis","volume":"19","author":"Csuka","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaut.2013.12.011_bib136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10753-012-9526-6","article-title":"Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis","volume":"36","author":"Wang","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.jaut.2013.12.011_bib137","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.60.3.348","article-title":"Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment","volume":"60","author":"Piccolo","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jaut.2013.12.011_bib138","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.60.3.348-a","article-title":"Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis","volume":"60","author":"Mase","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jaut.2013.12.011_bib139","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.2003.028233","article-title":"Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment","volume":"75","author":"Dionisiotis","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.jaut.2013.12.011_bib140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.45.2.382","article-title":"Myasthenia gravis during interferon alfa therapy","volume":"45","author":"Batocchi","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.011_bib141","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1210\/jc.2008-0935","article-title":"Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I","volume":"93","author":"Meloni","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaut.2013.12.011_bib142","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.016","article-title":"Central role of interferon-beta in thymic events leading to myasthenia gravis","volume":"52","author":"Cufi","year":"2014","journal-title":"J\u00a0Autoimmun"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113001583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113001583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:10:56Z","timestamp":1760256656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":142,"alternative-id":["S0896841113001583"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.12.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718229535.793519621","asserted-by":"object"}]},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}